Nitinol has arrived in minimally invasive glaucoma surgery, making symptom management for the progressive eye disease safer and personalized.
Glaucoma often remains asymptomatic until vision damage occurs, with angle-closure glaucoma requiring urgent medical attention due to acute symptoms. Risk factors include family history, age, ...
ALEXANDRIA, MN - January 24, 2026 - PRESSADVANTAGE - Individuals living with or at risk for glaucoma in the region can ...
Billings, MT - January 26, 2026 - PRESSADVANTAGE - Patients seeking expert care for glaucoma in the region are turning ...
Initial case conducted by Dr. David Godfrey at Glaucoma Associates of TexasThe IDE study will evaluate the safety and ...
Initial case conducted by Dr. David Godfrey at Glaucoma Associates of TexasThe IDE study will evaluate the safety and effectiveness of the company's Calibreye Titratable Glaucoma Therapy ...
Vietnam Investment Review on MSN
APAO 2026 ophthalmology congress coming to Hong Kong
HONG KONG SAR - Media OutReach Newswire - 28 January 2026 - The 41st Asia-Pacific Academy of Ophthalmology Congress (APAO ...
The issuer is solely responsible for the content of this announcement.
Andrew Tatham, MD, MBA, FRCOphth, FEBO, outlines the role of micro-invasive glaucoma surgery alongside established glaucoma ...
Please provide your email address to receive an email when new articles are posted on . After 1 year, patients with gas-permeable contact lenses had about 10 ETDRS letters greater visual acuity ...
Omidenepag isopropyl eye drops may increase nearsightedness in patients with glaucoma, leading to myopic shifts of 0.75 D or ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results